Overall I am pleased with the way PDN management have dealt with this raising. I suspect retail shareholders are happy to have been included in the 26 entitlement, at a time the U market is looking really positive, rather than the previous 70c CR just before the U price collapse that was only for Institutions...
I did find it strange that retail investors weren't able to subscribe for multiples of their entitlement, since my understanding of the concept of "underwriting" is to act as a backstop for shares that were not in demand.
It looks good however that both retailers and underwriters appear to be fighting over the % of the scraps left on the table.
I remember a year or two ago, when PDN was vulnerable to it's huge debt, John B was heavily criticised on this forum, I'd just like to give him a thumbs up for how he and his team have navigated a tricky couple of years. Hopefully onwards and upwards from here.
- Forums
- ASX - By Stock
- PDN
- Ann: Successful Completion of A$94.6M Retail Entitlement Offer
Ann: Successful Completion of A$94.6M Retail Entitlement Offer, page-31
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PDN (ASX) to my watchlist
|
|||||
Last
$13.80 |
Change
-0.190(1.36%) |
Mkt cap ! $4.125B |
Open | High | Low | Value | Volume |
$14.10 | $14.10 | $13.67 | $13.15M | 953.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 17228 | $13.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.81 | 2425 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 543 | 14.490 |
6 | 1339 | 14.270 |
1 | 510 | 14.030 |
1 | 1000 | 14.000 |
3 | 798 | 13.900 |
Price($) | Vol. | No. |
---|---|---|
13.110 | 2127 | 2 |
13.430 | 204 | 2 |
13.660 | 1698 | 2 |
13.800 | 600 | 1 |
13.830 | 62 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PDN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online